Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9161 |
High Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.8919 |
High Similarity |
NPD4584 |
Approved |
0.8544 |
High Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.8516 |
High Similarity |
NPD7298 |
Approved |
0.8509 |
High Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.8442 |
Intermediate Similarity |
NPD4017 |
Approved |
0.8312 |
Intermediate Similarity |
NPD3639 |
Approved |
0.8312 |
Intermediate Similarity |
NPD3641 |
Approved |
0.8312 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.8278 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD6030 |
Approved |
0.8194 |
Intermediate Similarity |
NPD6031 |
Approved |
0.8101 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.8101 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.8089 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.8082 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.807 |
Intermediate Similarity |
NPD7291 |
Discontinued |
0.8027 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.7947 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7904 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7904 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7871 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD3922 |
Approved |
0.7829 |
Intermediate Similarity |
NPD3921 |
Approved |
0.7829 |
Intermediate Similarity |
NPD3924 |
Approved |
0.7829 |
Intermediate Similarity |
NPD3923 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD6107 |
Approved |
0.7791 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD6996 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7763 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7753 |
Intermediate Similarity |
NPD7034 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD3920 |
Phase 2 |
0.7665 |
Intermediate Similarity |
NPD4166 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7616 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.761 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7595 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7586 |
Intermediate Similarity |
NPD8054 |
Approved |
0.758 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD2898 |
Approved |
0.7572 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD3110 |
Approved |
0.7566 |
Intermediate Similarity |
NPD3109 |
Approved |
0.7558 |
Intermediate Similarity |
NPD6297 |
Approved |
0.755 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.755 |
Intermediate Similarity |
NPD5109 |
Approved |
0.755 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD5312 |
Approved |
0.7544 |
Intermediate Similarity |
NPD5313 |
Approved |
0.7532 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7515 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7515 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7456 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7439 |
Intermediate Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD7110 |
Phase 1 |
0.7438 |
Intermediate Similarity |
NPD2421 |
Approved |
0.7438 |
Intermediate Similarity |
NPD2420 |
Approved |
0.7434 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7434 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7432 |
Intermediate Similarity |
NPD6612 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD5966 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD4083 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD6687 |
Approved |
0.7412 |
Intermediate Similarity |
NPD6688 |
Approved |
0.7412 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7412 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7407 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7386 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7386 |
Intermediate Similarity |
NPD4475 |
Approved |
0.7386 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7378 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7378 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7375 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.7375 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7368 |
Intermediate Similarity |
NPD27 |
Approved |
0.7353 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7305 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7305 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7301 |
Intermediate Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7293 |
Intermediate Similarity |
NPD6046 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD5720 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7277 |
Intermediate Similarity |
NPD3815 |
Phase 1 |
0.7277 |
Intermediate Similarity |
NPD3816 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD6876 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6875 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD2883 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7239 |
Intermediate Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD7153 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7213 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD6257 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD6618 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7188 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7182 |
Intermediate Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD7905 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD3656 |
Approved |
0.7167 |
Intermediate Similarity |
NPD3349 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD554 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD6380 |
Phase 1 |
0.7151 |
Intermediate Similarity |
NPD5087 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3977 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7127 |
Intermediate Similarity |
NPD3408 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD1044 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD6523 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD4098 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.7097 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD5708 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7081 |
Intermediate Similarity |
NPD6364 |
Approved |
0.7081 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7081 |
Intermediate Similarity |
NPD44 |
Approved |
0.7072 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD5267 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7047 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7044 |
Intermediate Similarity |
NPD1753 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7043 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7039 |
Intermediate Similarity |
NPD2971 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7039 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD7281 |
Phase 3 |
0.7039 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7280 |
Phase 3 |
0.7039 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7039 |
Intermediate Similarity |
NPD2968 |
Approved |
0.703 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD52 |
Approved |
0.703 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD7438 |
Suspended |
0.7024 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7024 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7019 |
Intermediate Similarity |
NPD2808 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.701 |
Intermediate Similarity |
NPD7225 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7 |
Intermediate Similarity |
NPD5967 |
Approved |
0.6995 |
Remote Similarity |
NPD5641 |
Discontinued |
0.6988 |
Remote Similarity |
NPD4727 |
Phase 1 |
0.6981 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6975 |
Remote Similarity |
NPD2459 |
Approved |
0.6975 |
Remote Similarity |
NPD2458 |
Approved |
0.6975 |
Remote Similarity |
NPD2460 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD1421 |
Approved |
0.6974 |
Remote Similarity |
NPD1420 |
Approved |
0.6971 |
Remote Similarity |
NPD6607 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD3763 |
Approved |
0.697 |
Remote Similarity |
NPD2874 |
Phase 2 |
0.6964 |
Remote Similarity |
NPD1337 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD4577 |
Approved |
0.6944 |
Remote Similarity |
NPD4578 |
Approved |
0.6943 |
Remote Similarity |
NPD3531 |
Approved |
0.6943 |
Remote Similarity |
NPD7477 |
Discontinued |
0.6943 |
Remote Similarity |
NPD3532 |
Approved |
0.6943 |
Remote Similarity |
NPD3530 |
Approved |
0.6941 |
Remote Similarity |
NPD2978 |
Approved |
0.6941 |
Remote Similarity |
NPD6738 |
Phase 2 |
0.6941
|
Remote Similarity |
NPD4585 |
Approved |